ARCA biopharma, Inc.Broomfield, CO United States
Company Description
ARCA biopharma is using genes to treat your heart. The biopharmaceutical company's lead candidate, Gencaro, is a beta-blocker being developed to treat chronic heart failure and other cardiovascular diseases. Having identified common genetic variations in the cardiac nervous system, ARCA biopharma believes those variations may help predict how well patients will respond to Gencaro. Pending regulatory approval, Gencaro may be marketed directly by the company or through partnerships. If approved, it will be the first genetically-targeted heart failure treatment. ARCA biopharma is also collaborating with
| 8001 Arista Place, Ste. 200 | Phone: 720-940-2200 | http://www.arcabiopharma.com |
| Broomfield, CO 80021 | Fax: 720-208-9261 | 
Map This Company |
| United States |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
ARCA biopharma, Inc. Rankings
Executives
| 17 executives listed for ARCA biopharma, Inc.'s Broomfield, CO location. | ||
| Chairman | Richard Brewer | |
|---|---|---|
| President, CEO, and Director | Michael Bristow | |
| CFO | PatrickWheeler | |
Financials
| Company Type | Public - NASDAQ: ABIO Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 14 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on ARCA biopharma, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
